Alyeska Investment Group, L.P. Autolus Therapeutics PLC Transaction History

Alyeska Investment Group, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.75 - $2.25 $2.19 Million - $2.81 Million	-1,250,000 Reduced 85.37%	214,300 $394,000
Q4 2022 Feb 14, 2023	BUY	$1.74 - $3.27 $2.55 Million - $4.79 Million	1,464,300 New	1,464,300 $2.78 Million
Q1 2021 May 17, 2021	BUY	$5.49 - $9.36 $235,504 - $401,515	42,897 Added 25.87%	208,706 $1.2 Million
Q4 2020 Feb 16, 2021	SELL	$8.13 - $12.79 $10,788 - $16,972	-1,327 Reduced 0.79%	165,809 $1.48 Million
Q3 2020 Nov 16, 2020	SELL	$11.64 - $16.3 $1.19 Million - $1.66 Million	-101,900 Reduced 37.88%	167,136 $1.95 Million
Q2 2020 Aug 14, 2020	SELL	$5.38 - $16.14 $203,476 - $610,430	-37,821 Reduced 12.33%	269,036 $4.31 Million
Q1 2020 May 15, 2020	BUY	$4.2 - $13.0 $418,093 - $1.29 Million	99,546 Added 48.02%	306,857 $1.84 Million
Q4 2019 Feb 14, 2020	BUY	$11.13 - $16.28 $371,118 - $542,840	33,344 Added 19.17%	207,311 $2.74 Million
Q3 2019 Nov 14, 2019	BUY	$9.79 - $16.72 $734,249 - $1.25 Million	75,000 Added 75.78%	173,967 $2.16 Million
Q2 2019 Aug 14, 2019	BUY	$15.1 - $31.25 $792,251 - $1.64 Million	52,467 Added 112.83%	98,967 $0
Q3 2018 Nov 14, 2018	SELL	$20.86 - $33.33 $1.64 Million - $2.62 Million	-78,500 Reduced 62.8%	46,500 $1.43 Million
Q2 2018 Aug 14, 2018	BUY	$25.0 - $27.75 $3.13 Million - $3.47 Million	125,000 New	125,000 $3.35 Million

104

163M

2.8K

13.4K

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $208M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.